Mode of action studies confirm on-target engagement of lysyl-tRNA synthetase inhibitor and lead to new selection marker for Cryptosporidium (2023)
Attributed to:
MICA: Development of new agents for the treatment of cryptosporidiosis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fcimb.2023.1236814
Publication URI: http://dx.doi.org/10.3389/fcimb.2023.1236814
Type: Journal Article/Review
Parent Publication: Frontiers in Cellular and Infection Microbiology